Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Coeptis Therapeutics Holdings, Inc. (COEP) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Coeptis Therapeutics Holdings, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1759186.
Total stock buying since 2022: $83,275.
Total stock sales since 2022: $862,433.
Total stock option exercises since 2022: $1,570,788.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 0 | $0 | 0 | $0 | 198,375 | $1,570,788 |
| 2024 | 61,770 | $42,306 | 0 | $0 | 0 | $0 |
| 2023 | 44,226 | $40,969 | 0 | $0 | 0 | $0 |
| 2022 | 0 | $0 | 85,305 | $862,433 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-02 | 0 | $0 | 0 | $0 | 198,375 | $1,570,788 |
| 2024-01 | 61,770 | $42,306 | 0 | $0 | 0 | $0 |
| 2023-08 | 44,226 | $40,969 | 0 | $0 | 0 | $0 |
| 2022-05 | 0 | $0 | 85,305 | $862,433 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-02-11 | Cogley Brian (Chief Financial Officer) | Option Ex | 10,000 | 10.56 | 105,600 |
| 2026-02-11 | Desilva Tara | Option Ex | 5,700 | 10.56 | 60,192 |
| 2026-02-11 | Cochran Christopher P. | Option Ex | 5,700 | 10.56 | 60,192 |
| 2026-02-11 | Sheehy Christine Elise (VP Compliance and Secy) | Option Ex | 1,000 | 10.56 | 10,560 |
| 2026-02-11 | Yerace Daniel Alexander (VP Operations) | Option Ex | 10,000 | 10.41 | 104,100 |
| 2026-02-11 | Mehalick David (CEO and President) | Option Ex | 148,875 | 7.05 | 1,049,568 |
| 2026-02-11 | Calise Chris | Option Ex | 5,700 | 10.56 | 60,192 |
| 2026-02-11 | Deschamps Philippe | Option Ex | 5,700 | 10.56 | 60,192 |
| 2026-02-11 | Salkind Gene | Option Ex | 5,700 | 10.56 | 60,192 |
| 2024-01-12 | Desilva Tara | Buy | 2,266 | .57 | 1,291 |
| 2024-01-10 | Cogley Brian (Chief Financial Officer) | Buy | 5,000 | .67 | 3,350 |
| 2024-01-08 | Mehalick David (CEO and President) | Buy | 20,004 | .67 | 13,302 |
| 2024-01-05 | Cochran Christopher P. | Buy | 7,000 | .77 | 5,390 |
| 2024-01-05 | Yerace Daniel Alexander (VP of Operations) | Buy | 10,850 | .69 | 7,486 |
| 2024-01-05 | Mehalick David (CEO and President) | Buy | 5,050 | .69 | 3,484 |
| 2024-01-05 | Salkind Gene | Buy | 11,600 | .69 | 8,003 |
| 2023-08-29 | Salkind Gene | Buy | 4,006 | 1.01 | 4,046 |
| 2023-08-25 | Salkind Gene | Buy | 28,638 | .91 | 26,060 |
| 2023-08-23 | Calise Chris | Buy | 11,582 | .94 | 10,863 |
| 2022-05-04 | Fortmiller Frederick Vincent Jr. | Sale | 85,305 | 10.11 | 862,433 |
Insider trading activities including stock purchases, stock sales, and option exercises of COEP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Coeptis Therapeutics Holdings, Inc. (symbol COEP, CIK number 1759186) see the Securities and Exchange Commission (SEC) website.